Prices for generic medications are skyrocketing out of sight.
In some cases they have more than double and tripled in cost. In some instances, when a patent on a medication expires, major pharma companies pay makers of generic meds millions of dollars not to manufacture them so that they can continue to charge the higher prices. At a time when our government administration is trying to hold the line on health care costs, this kind of behavior must not be tolerated. Regulations are needed.
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
